baber/WOPTO huggingface dataset:
Patent AT-E214744-T1 (AT)
Inventor: ALPERINE SERGE ALEXANDRE
IPC: F02C7/00
Filed: 1999-09-30
Granted: 2002-04-15
Abstract: A poorly conducting thermal barrier coating applied on a superalloy substrate comprises a mixture of oxides consisting of a composition based on zirconia, 3-15 weight % of an oxide, preferably yttria, that stabilizes the zirconia, 0.5-12 weight % of an additional metallic element selected from Ni, Co, Fe or a mixture of Ni and/or Co and/or Fe, or their oxides, and 0.02-0.1 weight % C. The homogeneous oxide mixture is deposited on the substrate by electron beam evaporation of a bar having a composition consisting of the above thermal barrier coating composition. The mixture can also be applied by thermal or plasma spraying, (plasma-assisted) chemical vapor deposition. A sublayer of nickel-aluminum alloy containing at least one metal selected from Cr, precious metals of crude platinum , yttrium and rare earths can be interposed between the substrate and the oxide mixture layer. Preferably the sublayer has formula MCrAlY, where M = at least one metal selected from Ni, Co and Fe. Independent claims are given for: (a) a superalloy metal piece whose surface is coated at least in part with the thermal barrier; and (b) a process for deposition of the thermal barrier on a superalloy substrate. The deposition process involves (i) mixing and sintering into the form of a bar a mixture of powders of zirconia, a zirconia-stabilizing oxide, and an element selected from Ni, Co and Fe; (ii) introducing the body to into an EB-PVD chamber previously loaded with the bar; and (iii) creating a vacuum in the chamber, preheating the substrate, and focussing an electron beam on the bar in order to vaporize the elements present in the bar so that they condense onto the substrate.   In (i), mixing of the powders is achieved by using a binder comprising a solvent that is at least partially rich in carbon, preferably a polyvinyl alcohol. A thermally crackable, carbon precursor gas selected from methane, ethane, butane, propane, an alkene or alkyne, is introduced into the deposition chamber in the immediate vicinity of the substrate to be coated.
Patent AT-E378734-T1 (AT)
Inventor: DOUTRELOIGNE JAN
IPC: G09G3/36
Filed: 1999-09-30
Granted: 2007-11-15
Abstract: A level-shifter architecture with high-voltage driving capability and extremely low power consumption, exploiting dynamic control of the charge on the gate electrodes of the high-voltage output transistors, is presented. Said architecture can be integrated in a CMOS technology and can be applied although not limited thereto for monolithic integration of high-voltage display driver circuits in battery-powered applications. <IMAGE>
Patent AT-E250692-T1 (AT)
Inventor: THEURER JOSEF
IPC: E01B29/32
Filed: 1999-08-03
Granted: 2003-10-15
Abstract: The track maintenance machine, for a railway permanent way (15) of rails (14) and sleepers (12), has a machine frame (3) and two spaced rail lifters (13) along the longitudinal line of the machine, with height adjustment and operated by drives (19). Each has a unit (8) to slide the sleepers, moved by a drive across the line of the track, and a press unit (10) to act on the sliding sleeper (12). A unit (23) to remove the intermediate layers, between the rails and sleepers, is between the rail lifters (13), with height adjustment.
Patent AT-E222287-T1 (AT)
Inventor: BLOCK CHRISTIAN
IPC: C11D3/39
Filed: 1999-01-07
Granted: 2002-08-15
Abstract: A process for the production of colored detergent particles. The process is characterized in that a slurry comprising at least one powdering agent and at least one dye is spray dried so that a colored powdering agent is formed. The thus formed colored powdering agent is then applied to detergent particles.
Patent AT-E279055-T1 (AT)
Inventor: HEICHLER JOHANNES
IPC: H04H20/28
Filed: 1999-04-09
Granted: 2004-10-15
Abstract: A base station for broadcasting or re-broadcasting of TV and/or audio and/or data signals, said station comprising:   means for transmitting downstream signals from said base station to at least one user terminal; means for receiving upstream signals transmitted from said at least one user terminal; means for transmitting a high-precision beacon signal as reference signal for the generation of said upstream signals.   <IMAGE>
Patent AT-E230818-T1 (AT)
Inventor: LARSEN THOR
IPC: F01C3/06
Filed: 1999-07-30
Granted: 2003-01-15
Abstract: A driving system (13) comprises a housing (10) having spherical hollow space (11), a rotatable main shaft (14), a driving means (16) and a piston construction (15). The piston construction (15) is rockable about a first rocking axis (15a) in a rectilinear motion backwards and forwards relative to a stationary wall portion (12). The driving means (16) is pivotally mounted in the main shaft (14) about a pivotable axis (16b) which forms an acute angle with the rotatable axis (14a) of the main shaft (14) and is rockably mounted in the piston construction (15) about a second rocking axis (16a), which extends at right angles to the first rocking axis (15a). The first and second rocking axis (15a, 16a) cross the rotational axis (14a) of the main shaft (14) at a common crossing point (11c) centrally in the spherical hollow space (11).
Patent AT-E232508-T1 (AT)
Inventor: NINANE LEON
IPC: C01D3/14
Filed: 1999-08-10
Granted: 2003-02-15
Abstract: Process for the production of sodium chloride crystals from a sodium chloride brine contaminated by potassium chloride and sulphate ions, according to which a calcium compound (32) is added to the brine (48) to crystallize glauberite (35), which is isolated, the resulting aqueous solution (36) is subjected to evaporation to crystallize sodium chloride (40), which is collected, and the aqueous mother liquor (41) from the crystallization of the sodium chloride is subjected to cooling (42) to crystallize glaserite (45).
Patent AT-E310848-T1 (AT)
Inventor: SUN GANG
IPC: D06B1/00
Filed: 1999-09-10
Granted: 2005-12-15
Abstract: The present invention provides durable and refreshable antimicrobial polymers and methods for preparing the same. In some instances, the polymer is a textile. These textiles have excellent colorfastness and washfastness. The antimicrobial fabrics of this invention are suitable for sportswear, antiodor carpets, films, plastics, toys and medical uses.
Patent AT-E238194-T1 (AT)
Inventor: CHAPUIS LAURENT
IPC: B63H9/06
Filed: 1999-10-12
Granted: 2003-05-15
Abstract: A low-stretch, flexible composite, made of one or several sections, particularly useful for making a sail (2), includes first and second polymer films (52, 62) with discontinuous, stretch-resistant segments (16) therebetween. The segments extend generally along the load lines (17) for the sail. The segments have lengths which are substantially shorter than corresponding lengths of the load lines within each section. The ends of the segments are laterally staggered relative to one another. Mats (20) of generally parallel mat elements can be used as the segments. The mat elements typically include discrete multifiber yarns (24, 26) and/or a fiber array (22), typically created by pneumatically laterally spreading apart the fibers of an untwisted multifiber yarn (32). A laminating assembly includes first and second flexible pressure sheets (66, 68), defining a sealable lamination interior (82) containing the material stack (64) to be laminated, housed within an enclosure (90). A partial vacuum is created within the lamination interior and heated fluid is circulated in contact with the pressure sheets to quickly and uniformly heat the pressure sheets and the material stack being laminated.
Patent AT-E220574-T1 (AT)
Inventor: HERZAN GEORG
IPC: B41F5/06
Filed: 1999-09-28
Granted: 2002-08-15
Abstract: A coating machine for applying a flowable coating substance to a sheet material to improve its surface. The coating machine has a series construction which lends itself to easy modification and versatile use. The coating machine includes, in a sheet conveyance direction, a first coating unit for applying a flowable substance to a front side of the sheet material, a sheet turning unit for reversing the position of the sheet, a first coating unit for applying a flowable substance to a reverse side of the sheet material, and sheet delivery unit. The coating units may have similar or identical constructions with interchangeable dosing systems.
Patent AT-E303881-T1 (AT)
Inventor: FARROW NIGEL RICHARD
IPC: B24C1/00
Filed: 1999-12-06
Granted: 2005-09-15
Abstract: A method of removing a coating, such as paint, varnish, biological growth or grime, from a surface, the method comprising selecting a suitable particulate solid having a particular size of from 150-250 mm and a fluid carrier to form a spray mixture and spraying the mixture as a jet spray so as to impact and at least partially remove the coating. The hardness of the particulate solid is less than 8.0 on the Moh scale. The pressure applied to the spray mixture to generate the spray is from 3 x 10 5  to 1.5 x 10 6  Nm -2 . An apparatus comprising a blasting pot (1) and a compressor (2) to generate the spray mixture and propel it from a nozzle (5) is also disclosed. Heating may be applied to the carrier, either prior to or when mixing with the particulate solid.
Patent AT-E286398-T1 (AT)
Inventor: YELLE WILLIAM E
IPC: C07D495/04
Filed: 1999-11-22
Granted: 2005-01-15
Abstract: Methods and compositions are disclosed utilizing N-desmethylolanzapine for the treatment of psychosis in humans. N-Desmethylolanzapine exhibits a lessened liability toward drug-drug interactions than olanzapine and a more predictable dosing regimen than olanzapine. N-Desmethylolanzapine is also useful for the treatment of acute mania, mild anxiety states, anxiety disorders, schizophrenia, bipolar disorder, attention deficit hyperactivity disorder, autistic disorder, excessive aggression, substance abuse, depressive signs and symptoms, tic disorder, functional bowel disorder and fungal dermatitis.
Patent AT-E277020-T1 (AT)
Inventor: BRADBURY ROBERT HUGH
IPC: A61K31/505
Filed: 1999-12-20
Granted: 2004-10-15
Abstract: A pyrimidine derivative of formula (I):wherein: R1 is an optional substituent as defined within; Rx is selected from halo, hydroxy, nitro, amino, cyano, mercapto, carboxy, sulphamoyl, formamido, ureido or carbamoyl or a group of formula (Ib): A-B-C- as defined within; Q1 and Q2 are independently selected from aryl, a 5- or 6-membered monocyclic moiety; and a 9- or 10-membered bicyclic heterocyclic moiety; and one or both of Q1 and Q2 bears on any available carbon atom one substituent of formula (Ia) as defined within; and Q1 and Q2 are optionally further substituted; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof; are useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
Patent DE-974350-T1 (DE)
Inventor: MORI MASAO
IPC: A61K9/70
Filed: 1997-02-06
Abstract: An external preparation containing tranilast which is excellent in the release of the active ingredient contained therein, achieves a high percutaneous absorption, fully ensures the effective drug concentration in the skin tissue and little irritates the skin. This preparation is composed of an aqueous base containing as the active ingredient tranilast, its salt or a mixture thereof. The aqueous base contains a solubilizer for tranilast, a dispersant, an absorption aid, an adhesive and/or a shape retenting agent, and water. The active ingredient has been solubilized by the above-mentioned solubilizer and dispersed in the aqueous base by the above-mentioned dispersant.
Patent ES-2178980-T1 (ES)
Inventor: GRADON LEWIS GEORGE
IPC: A62B18/02
Filed: 2001-06-13
Abstract: A improved nasal mask is disclosed for delivering CPAP therapy to patients. The nasal mask has a sliding engagement to the headgear. The sliding engagement allows substantial relative lateral movement eg: when face is distorted from sleeping on side, while still providing adequate compressive force to avoid side leakage. The sliding engagement also allows easy release from the headgear.
Patent ES-2312308-T1 (ES)
Title: Formulaciones de liberacion sostenida de topiramato.
Inventor: LIANG LIKAN
IPC: A61K31/357
Filed: 2007-11-16
Abstract: Una formulación de liberación sostenida de topiramato para administración oral a un sujeto mamífero que comprende topiramato como ingrediente activo, que se libera de la formulación siguiendo un perfil de liberación predeterminado, comprendiendo dicha formulación un componente de liberación prolongada (XR).
Patent CY-1107426-T1 (CY)
Title: Νεα παραγωγα φθοριογλυκοσιδιων απο πυραζολες, φαρμακευτικα προϊοντα που περιεχουν τις εν λογω ενωσεις και η χρηση αυτων
Inventor: BRUMMERHOP HARM
IPC: A61P3/10
Filed: 2008-02-04
Abstract: Η εφεύρεση αφορά σε υποκατεστημένα παράγωγα φθοριογλυκοσιδίων από πυραζόλες του τύπου (I), όπου οι ρίζες έχουν τις αναφερόμενες σημασίες, καθώς και στα φυσιολογικά ανεκτά άλατά τους και μεθόδους για την παρασκευή αυτών. Οι ενώσεις είναι για παράδειγμα κατάλληλες ως αντιδιαβητικά.
Patent CY-1108395-T1 (CY)
Inventor: UCHIDA JUNJI
IPC: A61K31/53
Filed: 2008-10-06
Abstract: The present invention provides an antitumor effect potentiator for enhancing antitumor activity of an antitumor agent comprising tegafur in a therapeutically effective amount, gimeracil in an amount effective for enhancing an antitumor effect, and oteracil potassium in an amount effective for inhibiting a side effect. The antitumor effect potentiator comprising at least one member selected from the group consisting of folinic acid and pharmacologically acceptable salts thereof. The present invention also provides a method for enhancing an antitumor effect of an antitumor agent comprising the step of administering to a patient the aforementioned antitumor effect potentiator; a method for inhibiting the growth of a tumor comprising the step of administering to a patient the aforementioned antitumor effect potentiator and a method for cancer treatment comprising the step of administering to a patient the aforementioned antitumor agent.
Patent CY-1109121-T1 (CY)
Inventor: BURNIE JAMES PETER
IPC: A61K45/06
Filed: 2009-06-09
Abstract: A composition comprising an antibody or antigen binding fragments thereof. The antibody is specific for at least one epitope of hsp90 from an organism of the  Aspergillus  genus. The composition also comprises the antifungal agent posaconazole.
Patent CY-1110113-T1 (CY)
Inventor: KOZAK ALEXANDER
IPC: C07F9/10
Filed: 2010-05-28
Abstract: The present invention relates to compounds, which are phospholipid derivatives of valproic acid, to compositions comprising said compounds and their use for treating epilepsy, migraine, bipolar disorders and pain.
Patent CY-1112620-T1 (CY)
Inventor: WRAITH DAVID
IPC: A61P37/00
Filed: 2011-10-25
Abstract: The present invention relates to a composition which comprises the following myelin basic protein peptides: MBP 30-44; MBP 83-99; MBP 131-145; and MBP 140-154. The composition may be used to treat a disease, in particular multiple sclerosis and/or optical neuritis and the invention also relates to such uses and methods.
Patent CY-1112303-T1 (CY)
Title: Παραγωγα (4-(4-[6-(τριφθορομεθυλ-πυριδιν-3-υλαμινο)-ν-περιεχοντα-ετεροαρυλ]-φαινυλ)-κυκλοεξυλ)-οξικου οξεος και φαρμακευτικες χρησεις εξ' αυτων
Inventor: SERRANO-WU MICHAEL H
IPC: C07D413/10
Filed: 2012-01-18
Abstract: Η παρούσα εφεύρεση παρέχει οργανικές ενώσεις της ακόλουθης δομής· Α-L1-Β-C-D-L2-Ε που είναι χρήσιμες για την αγωγή ή πρόληψη καταστάσεων ή διαταραχών που συσχετίζονται με την δραστηριότητα της DGΑΤ1 σε ζώα, ειδικότερα δε σε ανθρώπους.
Patent CY-1116431-T1 (CY)
Title: Αυτονομο υποβρυχιο οχημα για την αποκτηση γεωφυσικων δεδομενων
Inventor: GIORI ITALIANO
IPC: G01V11/00
Filed: 2015-06-26
Abstract: Η παρούσα εφεύρεση έχει ως πρώτο αντικείμενο, αυτόνομο υποβρύχιο όχημα εξοπλισμένο για την απόκτηση της βαρυτομετρικής και μαγνητικής κλίσης κοντά στον πυθμένα της θάλασσας, χαρακτηρίζεται από το ότι περιλαμβάνει: - τουλάχιστον ένα βαρυτομετρικό κλισίμετρο, - τουλάχιστον ένα μαγνητικό κλεισίμετρο. Συγκεκριμένα, το εν λόγω αυτόνομο εξοπλισμένο όχημα επιτρέπει υποβρύχιες εξερευνήσεις έως και 3.000 μέτρα. Ένα δεύτερο αντικείμενο της παρούσας εφεύρεσης σχετίζεται με μέθοδο ανάλυσης των γεωφυσικών χαρακτηριστικών του υπεδάφους, που περιλαμβάνει την απόκτηση της βαρυτομετρικής και μαγνητικής κλίσης σε ένα υποθαλάσσιο περιβάλλον που χαρακτηρίζεται από τις παρακάτω φάσεις - χρήση αυτόνομου εξοπλισμένου υποβρύχιου οχήματος σύμφωνα με την παρούσα εφεύρεση - βύθιση του εν λόγω οχήματος στην περιοχή του πυθμένα της θάλασσας, - πλοήγηση κατά μήκος μιας προγραμματισμένης διαδρομής, - απόκτηση και αποθήκευση των δεδομένων που συλλέγονται από τα εν λόγω κλισίμετρα και τα εν λόγω όργανα σε συσχετισμό με το γεωγραφικό σημείο μέτρησης, - ανάκτηση των δεδομένων που συλλέγονται και χρήση τους για την γεωφυσική ανάλυση του υπεδάφους.
Patent CY-1124143-T1 (CY)
Title: Οστικες μορφογενετικες πρωτεϊνες
Inventor: MORRELL NICHOLAS W
IPC: A61K38/18
Filed: 2021-05-14
Abstract: Η εφεύρεση αναφέρεται σε νέες παραλλαγές οστικής μορφογενετικής πρωτεΐνης 9 (ΒΜΡ9) και σε φαρμακευτικές συνθέσεις που περιλαμβάνουν τις εν λόγω παραλλαγές. Η εφεύρεση αναφέρεται επίσης σε ένα πολυπεπτίδιο που επιλέγεται από την οστική μορφογενετική πρωτεΐνη 10 (ΒΜΡ10) και μία παραλλαγή ΒΜΡ9 που στερούνται οστεογόνου δραστικότητας, για χρήση στην αγωγή μίας αγγειακής νόσου ή μίας αναπνευστικής νόσου.
Patent CY-1124210-T1 (CY)
Title: Τετραϋδροπυρανυλ αμινο-πυρρολοπυριμιδινονη και μεθοδοι χρησης αυτης
Inventor: LAPIERRE JEAN-MARC
IPC: C07D487/04
Filed: 2021-05-31
Abstract: Η αίτηση αφορά σε ένωση του Τύπου (Ι) ή φαρμακευτικώς αποδεκτό άλας αυτής, ταυτομερές, προφάρμακο, διαλύτωμα, μεταβολίτη, πολύμορφο, ανάλογο ή παράγωγο αυτής, που ρυθμίζει τη δραστικότητα της ΒΤΚ, φαρμακευτική σύνθεση που περιλαμβάνει την ένωση του Τύπου (Ι), και μέθοδο θεραπείας ή πρόληψης ασθένειας στην οποία η ΒΤΚ παίζει ένα ρόλο.
Patent CY-1126063-T1 (CY)
Title: Τρωκτικα που εκφραζουν εξωγενη τερματικη δεοξυνουκλεοτιδυλοτρανσφεραση
Inventor: MACDONALD LYNN
IPC: A01K67/027
Filed: 2023-05-31
Abstract: Παρέχονται εδώ μέθοδοι και συνθέσεις που σχετίζονται με μη ανθρώπινα ζώα που εκφράζουν εξωγενή Τερματική Δεοξονουκλεοτιδυλοτρανσφεράση (TdT).
Patent HR-P20120198-T1 (HR)
Inventor: ISRAELS RAFEL
IPC: A01N25/00
Filed: 2012-03-01
Abstract: Kristalni kompleks koji sadrži najmanje jedan poljoprivredni aktivni organski spoj A izabran iz grupe koju čine piraklostrobin, epoksikonazol i metkonazol, i tiofanat-metil.  Patent sadrži još 11 patentnih zahtjeva.
Patent HR-P20130551-T1 (HR)
Title: Bioeffective krill oil compositions
Inventor: BRUHEIM INGE
IPC: A61K35/612
Filed: 2013-06-17
Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO 2  or CO2 plus approximately 5% of a cosolvent. Stage 2 extract the actual krill oils by using supercritical CO 2  in combination with approximately 20% ethanol. The krill oil materials obatined are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
Patent SI-1064935-T1 (SI)
Title: Solid controlled-release pharmaceutical compositions prepared by means of a thermoforming process
Inventor: WUTHRICH PATRICK
IPC: A61K47/32
Filed: 2000-06-27
Abstract: Controlled release solid pharmaceutical compositions containing an active material and one or more polymethacrylates. The compositions are prepared by thermoforming a mixture of the active material and the polymethacrylate(s), the release properties being determined by the nature of the polymethacrylate(s), their relative amounts, and the technique used to make the compositions. Preferably the polymethacrylate(s) are Eudragit (RTM) RL and/or RS, optionally with Eudragit E. The ingredients are mixed and then thermoformed at 60 - 150 degrees C, preferably 80 - 130 degrees C by an extrusion or injection process. The use of a co-extrusion or co-injection procedure, in which the inner and outer layers have different compositions is particularly preferred. Additional components that may be incorporated include antioxidants, flavors, colors, preservatives, sweeteners, and anti-adherents.
Patent SI-1501720-T1 (SI)
Title: Vessel with a bottom air cavity having an air deflector
Inventor: MATVEEV KONSTANTIN
IPC: B63B1/00
Filed: 2003-05-05
Abstract: The invention relates to an air cavity vessel (1) comprising a hull (3) with a bow (11), a stern (12) and a propeller (13) near the stern, at least one open cavity (4,5,6) being formed at the bottom (2) of the hull, and air injection means (7,10) for supplying air into the cavity. The vessel is provided with at least one air deflector (15,16,17), extending between the rearmost cavity (21,22) and the propeller (13), the deflector extending in a transverse direction from a longitudinal centre line (25) of the vessel to the sides of the vessel and having a sloping surface (27) extending from the hull (29) upwardly when going towards the stern (12). <IMAGE>
Patent SI-1437668-T1 (SI)
Title: Method for conducting a cashless payment of goods or services using a mobile radio terminal
Inventor: KRAUSE ROLF
IPC: G06Q20/00
Filed: 2003-01-08
Abstract: Stored in a central computer unit (CCU) and a mobile telephone (MT), an encoded logical record acts as main registration (MR), identifies the MT and has user data. As a transaction identification (TID) is queried, on passing to the CCU, the MT's MR is compared with the data stored in the CCU and authorized. A service/goods supplier sends the TID with TID data to the CCU to complete a purchase.
Patent SI-1565210-T1 (SI)
Title: Clostridial neurotoxin for use in the treatment of nasal congestion
Inventor: SANDERS IRA
IPC: A61K38/095
Filed: 2003-11-20
Abstract: A method is disclosed for blocking or reducing a physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of a therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.
Patent SI-1587514-T1 (SI)
Title: A rapid-acting pharmaceutical composition
Inventor: NYSTRIM CHRISTER
IPC: A61K9/20
Filed: 2004-01-15
Abstract: A pharmaceutical composition for the treatment of acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent in the form of microparticles which are adhered to the surfaces of carrier particles which are substantially larger than the particles of the active agent or agents, and are essentially insoluble or sparingly soluble in water, in combination with a bioadhesion and/or mucoadhesion promoting agent adhered to the surfaces of said carrier particles. The composition is primarily intended for sublingual or intranasal administration. The invention also relates to a method for preparing the composition and to the use of the composition for the treatment of acute disorders.
Patent SI-1983013-T1 (SI)
Title: Epoxy resins with improved elasticity
Inventor: GRASBOCK ROSEMARIA
IPC: C08G59/18
Filed: 2005-07-18
Abstract: An epoxy resin AB comprising, in its polymer chain, moieties derived from aliphatic polyethers  B1  having at least 4 carbon atoms in the alkylene group or from aliphatic polyesters  B2  based on linear, branched or cyclic aliphatic polyhydric alcohols  B21  and linear, branched or cyclic aliphatic polyvalent acids  B22,  where the average number of hydroxyl or acid groups in  B21  or  B22  is at least 1.9, a process for its preparation, and a method of use thereof to make elastic coating films that impart good corrosion resistance even in thin layers